Anteris Technologies Global (NASDAQ:AVR) Hits New 1-Year High – What’s Next?

Anteris Technologies Global Corp. (NASDAQ:AVR) hit a new 52-week high on Thursday . The company traded as high as $7.10 and last traded at $7.05, with a volume of 327708 shares traded. The stock had previously closed at $6.53.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on AVR. Cantor Fitzgerald reiterated an “overweight” rating and issued a $15.00 target price on shares of Anteris Technologies Global in a research note on Friday, March 27th. Lake Street Capital reissued a “buy” rating and set a $15.00 price target on shares of Anteris Technologies Global in a research report on Friday, January 23rd. Wells Fargo & Company assumed coverage on shares of Anteris Technologies Global in a report on Wednesday, March 11th. They issued an “overweight” rating and a $16.00 price target on the stock. Wall Street Zen raised shares of Anteris Technologies Global from a “sell” rating to a “hold” rating in a research report on Saturday. Finally, Barclays upped their price target on Anteris Technologies Global from $17.00 to $18.00 and gave the stock an “overweight” rating in a research report on Friday. Four analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Anteris Technologies Global has an average rating of “Moderate Buy” and a consensus target price of $16.00.

Anteris Technologies Global Price Performance

The stock has a market capitalization of $704.76 million, a PE ratio of -3.25 and a beta of 1.32. The business’s fifty day moving average price is $5.95 and its two-hundred day moving average price is $5.36.

Anteris Technologies Global (NASDAQ:AVR) last issued its earnings results on Tuesday, May 12th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). Anteris Technologies Global had a negative return on equity of 124.76% and a negative net margin of 5,148.78%.The firm had revenue of $0.49 million during the quarter, compared to analysts’ expectations of $0.77 million. During the same quarter last year, the business earned ($0.61) EPS. As a group, equities research analysts anticipate that Anteris Technologies Global Corp. will post -1.54 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Anteris Technologies Global

Institutional investors and hedge funds have recently modified their holdings of the company. L1 Capital Pty Ltd boosted its position in Anteris Technologies Global by 143.2% in the third quarter. L1 Capital Pty Ltd now owns 6,838,136 shares of the company’s stock valued at $30,772,000 after buying an additional 4,026,136 shares during the last quarter. JPMorgan Chase & Co. raised its position in Anteris Technologies Global by 9,958.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 1,068,328 shares of the company’s stock worth $4,049,000 after buying an additional 1,057,707 shares during the last quarter. ADAR1 Capital Management LLC lifted its stake in Anteris Technologies Global by 526.9% during the 4th quarter. ADAR1 Capital Management LLC now owns 1,238,777 shares of the company’s stock valued at $6,181,000 after acquiring an additional 1,041,162 shares during the period. Nantahala Capital Management LLC boosted its holdings in shares of Anteris Technologies Global by 31.9% in the 4th quarter. Nantahala Capital Management LLC now owns 2,530,910 shares of the company’s stock valued at $12,629,000 after acquiring an additional 612,244 shares during the last quarter. Finally, Militia Capital Management LLC purchased a new stake in shares of Anteris Technologies Global in the 1st quarter valued at $3,358,000.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.